While in the clinical demo working experience with Xyrem in narcolepsy/cataplexy people at therapeutic doses, two clients documented nervousness and a single noted sleeplessness subsequent abrupt discontinuation in the termination in the scientific trial; in the two patients with panic, the frequency of cataplexy had greater markedly concurrently.G